ClinicalTrialsFinder

Active Immunisation for Chikungunya Virus Infection Clinical Trials in Delhi, The National Capital Territory (nct) of Delhi

1 recruitingDelhi, The National Capital Territory (nct) of Delhi, India

Showing 1–1 of 1 trials

Recruiting
Phase 2Phase 3

A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age.

Active Immunisation for Chikungunya Virus Infection
Bharat Biotech International Limited1,000 enrolled10 locationsNCT07555392